NeuraSignal

We’re live at #ACC25 in Chicago! Come see us at booth #8076 and discover how NeuraSignal is advancing PFO detection with fully robotic TCD.

Ever heard of a "Bubble Study"? It’s a powerful technique that helps detect hidden heart defects like a PFO (Patent Foramen Ovale), especially in patients who’ve had unexplained strokes. At NeuraSignal, we break down what a Bubble Study is, how it works, and why it matters for stroke prevention and diagnosis. ???? ?? Read the full blog: https://bit.ly/43sO4OP

?? Join NeuraSignal at AAN 2025 in San Diego! ?? Heading to the American Academy of Neurology (AAN) Annual Meeting? Make sure to stop by Booth #1747 from April 5-9, 2025 to see how intelligent ultrasound is transforming neurovascular care! ??? ?? Experience NG2 Intelligent Ultrasound in action ?? Learn how AI-powered real-time cerebral blood flow monitoring is shaping stroke and vasospasm detection ?? Connect with our team and explore the future of TCD ultrasound ?? Mark your calendars & visit us at Booth 1747! We can’t wait to see you in San Diego! #NeuraSignal #AAN2025 #Neurology

?? What is Transcranial Doppler (TCD) Ultrasound, and Why Does It Matter? TCD is a powerful, non-invasive tool that provides real-time insights into cerebral blood flow, helping clinicians detect conditions like stroke, vasospasm, and brain injury complications. Want to learn more about how TCD works and why it's a game-changer in neurovascular care? Check out our latest blog post! ?? Read here: https://bit.ly/4kxi8yR #NeuraSignal #TCDUltrasound #StrokeCare

Fresh off the Presses! NeuraSignal is revolutionizing stroke care with real-time, intelligent ultrasound! ??? We’re thrilled to see the NG2 Intelligent Ultrasound featured in this latest AP News release, highlighting its impact on stroke detection, vasospasm monitoring, and patient outcomes. With advanced automation and AI-driven insights, we’re making Transcranial Doppler (TCD) ultrasound more accessible, reliable, and powerful than ever before. ?? Read the full story: https://bit.ly/3FAFljA Join us in shaping the future of neurovascular care. #NeuraSignal #NG2 #StrokeCare

For the first time ever, NeuraSignal is exhibiting at the American College of Cardiology (ACC) Annual Meeting in Chicago, March 29-31! ?? Visit us at Booth #8076 to see how the NG2 Intelligent Ultrasound achieves 3X the detection rate compared to TTE for PFO in proven real-world clinical settings. Don't miss this opportunity to experience cutting-edge innovation and chat with our experts! See you there! ?? #ACC24 #NeuraSignal

?? Celebrating Women in Medicine for National Women's Month! ?? This month, we honor the incredible women who are shaping the future of medicine, from groundbreaking research to life-saving patient care. At NeuraSignal, we are proud to support and work alongside the brilliant women advancing neurology, cardiology, and stroke care every day. Your dedication, innovation, and leadership inspire us all! Thank you for your impact on healthcare and the lives you change. Tag a woman in medicine who inspires you! ?????? #WomenInMedicine #NationalWomensMonth #NeuraSignal #HealthcareInnovation

Take it from Willy – See More, Treat More! ?? NeuraSignal’s NG2 Intelligent Ultrasound detects right-to-left shunts (RLS) 3X better than standard TTE, meaning more treatable cases are found, and fewer go undetected. ?? 27% detection vs. just 10% with traditional methods ?? More accuracy. More interventions. Better outcomes. When it comes to stroke prevention and PFO detection, seeing the whole picture makes all the difference. #NeuraSignal #NG2 #PFO

Peer-Reviewed & Published: NG2 Redefines RLS & PFO Detection! ?? Exciting news! We’re thrilled to announce that a groundbreaking study by Dr. Thomas Devlin and his research team has been accepted and published in Frontiers of Neurology. This study highlights how robotic transcranial Doppler (raTCD) significantly outperforms transthoracic echocardiography (TTE) in detecting right-to-left shunts (RLS) and patent foramen ovale (PFO)—critical factors in cryptogenic stroke. ?? Key Findings: ? 60.1% RLS detection with raTCD vs. 37.2% with TTE (p < 0.001) ? 42.6% detection of large shunts vs. 23.0% with TTE (p < 0.001) ? 92% sensitivity & 87.5% specificity—outperforming TTE (78.57% & 71.43%) ? 100% correct identification of large shunts in PFO closure patients, while TTE missed or underestimated PFO size in 44% of cases ?? Why This Matters: These results reinforce NG2 as a superior, non-invasive screening tool for PFO detection and stroke prevention. By accurately identifying large shunts, NG2 helps guide treatment decisions and improve patient outcomes—ensuring fewer missed diagnoses and better stroke prevention strategies. Read the full publication here: https://bit.ly/41rkciT

?? February is American Heart Month! ?? At NeuraSignal, we’re dedicated to advancing stroke and cardiac care through smarter, more precise ultrasound technology. This month, we join the movement to raise awareness about heart health, early detection, and innovation in cardiovascular care. Did you know? Undetected right-to-left shunts (RLS) can increase stroke risk—but with NG2 Intelligent Ultrasound, clinicians can detect 3X more shunts compared to standard TTE imaging. More detection means more opportunities for intervention and better patient outcomes. Let’s work together to protect hearts and prevent strokes. ???? #AmericanHeartMonth